1087 related articles for article (PubMed ID: 8720310)
21. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
[TBL] [Abstract][Full Text] [Related]
22. Effect of a novel xanthine derivative on experimental ulcers in rats.
Tanaka T; Morioka Y; Gebert U
Arzneimittelforschung; 1993 May; 43(5):558-62. PubMed ID: 8329000
[TBL] [Abstract][Full Text] [Related]
23. Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086).
Barzaghi F; Cesana R; Delevallée F; Fournex R; Nencioni A; Vincent JC; Deraedt R
Arzneimittelforschung; 1985; 35(9):1412-6. PubMed ID: 4084342
[TBL] [Abstract][Full Text] [Related]
24. Effect of a new potent H2-blocker, 3-[[[2-(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoyl propionamidine (YM-11170), on gastric secretion, ulcer formation and weight of male accessory sex organs in rats.
Takeda M; Takagi T; Yashima Y; Maeno H
Arzneimittelforschung; 1982; 32(7):734-7. PubMed ID: 6127086
[TBL] [Abstract][Full Text] [Related]
25. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
[TBL] [Abstract][Full Text] [Related]
26. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
[TBL] [Abstract][Full Text] [Related]
27. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
28. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
[TBL] [Abstract][Full Text] [Related]
29. Anti-ulcer compound from Voacanga africana with possible histamine H2 receptor blocking activity.
Tan PV; Nyasse B
Phytomedicine; 2000 Dec; 7(6):509-15. PubMed ID: 11194180
[TBL] [Abstract][Full Text] [Related]
30. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
Kinoshita M; Saito N; Tamaki H
Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
[TBL] [Abstract][Full Text] [Related]
31. Mucus and pepsin role in gastric damage prevention by H2-receptor antagonists and antiulcer drugs.
Impicciatore M; Morini G; Chiavarini M; Plazzi PV; Agosti A; Soldani G
Acta Physiol Hung; 1984; 64(3-4):253-7. PubMed ID: 6152367
[TBL] [Abstract][Full Text] [Related]
32. Gastric antisecretory and antiulcer/cytoprotective effects of 2-cyano-3-(ethylthio-3-methylthio)-2-propenoic acid methyl ester.
Borella LE; DiJoseph JF
Arzneimittelforschung; 1989 May; 39(5):598-601. PubMed ID: 2547390
[TBL] [Abstract][Full Text] [Related]
33. Histamine in stress ulcer prophylaxis in rats.
Warzecha Z; Dembiński A; Brzozowski T; Ceranowicz P; Dembiński M; Stachura J; Konturek SJ
J Physiol Pharmacol; 2001 Sep; 52(3):407-21. PubMed ID: 11596859
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
Okabe S; Shimosako K; Amagase K
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
[TBL] [Abstract][Full Text] [Related]
35. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
Okabe S; Narita M; Nakaji S; Takinami Y; Kawano O; Misaki N
Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and pharmacological characteristics of a newly synthesized H+-K+ ATPase inhibitor, YJA20379-1, 2-amino-4,5-dihydro-8-phenylimidazole[2,1-b]thiazolo[5,4-g]benzothiazol e.
Sohn SK; Chang MS; Choi WS; Kim KB; Woo TW; Lee SB; Chung YK
Can J Physiol Pharmacol; 1999 May; 77(5):330-8. PubMed ID: 10535682
[TBL] [Abstract][Full Text] [Related]
37. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
[TBL] [Abstract][Full Text] [Related]
38. Gastric antisecretory and antiulcer effects of simvastatin in rats.
Tariq M; Khan HA; Elfaki I; Arshaduddin M; Al Moutaery M; Al Rayes H; Al Swailam R
J Gastroenterol Hepatol; 2007 Dec; 22(12):2316-23. PubMed ID: 17593225
[TBL] [Abstract][Full Text] [Related]
39. Gastroprotective effect of earthworm paste (Lampito mauritii, Kinberg) on experimental gastric ulcer in rats.
Prakash M; Gunasekaran G
Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):171-6. PubMed ID: 20391954
[TBL] [Abstract][Full Text] [Related]
40. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
